0001415889-21-003715.txt : 20210726
0001415889-21-003715.hdr.sgml : 20210726
20210726180756
ACCESSION NUMBER: 0001415889-21-003715
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210722
FILED AS OF DATE: 20210726
DATE AS OF CHANGE: 20210726
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sheena Jonathan
CENTRAL INDEX KEY: 0001646649
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37478
FILM NUMBER: 211115308
MAIL ADDRESS:
STREET 1: C/O NATERA, INC.
STREET 2: 201 INDUSTRIAL ROAD, SUITE 410
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Natera, Inc.
CENTRAL INDEX KEY: 0001604821
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 010894487
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 13011 MCCALLEN PASS
STREET 2: BUILDING A SUITE 100
CITY: AUSTIN
STATE: TX
ZIP: 78753
BUSINESS PHONE: 650-249-9090
MAIL ADDRESS:
STREET 1: 13011 MCCALLEN PASS
STREET 2: BUILDING A SUITE 100
CITY: AUSTIN
STATE: TX
ZIP: 78753
4
1
form4-07262021_030719.xml
X0306
4
2021-07-22
0001604821
Natera, Inc.
NTRA
0001646649
Sheena Jonathan
C/O NATERA, INC.
13011 MCCALLEN PASS BUILDING A SUITE 100
AUSTIN
TX
78753
true
false
false
true
CO-FOUNDER
Common Stock
2021-07-22
4
M
0
187
5.3953
A
455817
D
Common Stock
2021-07-22
4
M
0
65
9.59
A
455882
D
Common Stock
2021-07-22
4
M
0
400
10.41
A
456282
D
Common Stock
2021-07-22
4
M
0
700
9.29
A
456982
D
Common Stock
2021-07-22
4
S
0
887
121.3602
D
456095
D
Common Stock
2021-07-22
4
S
0
300
122.3633
D
455795
D
Common Stock
2021-07-22
4
S
0
165
123.3111
D
455630
D
Stock Option (right to buy)
5.3953
2021-07-22
4
M
0
187
0
D
2024-12-09
Common Stock
187
1328
D
Stock Option (right to buy)
9.59
2021-07-22
4
M
0
65
0
D
2026-04-07
Common Stock
65
40335
D
Stock Option (right to buy)
10.41
2021-07-22
4
M
0
400
0
D
2027-06-08
Common Stock
400
35280
D
Stock Option (right to buy)
9.29
2021-07-22
4
M
0
700
0
D
2028-03-08
Common Stock
700
17346
D
The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2021.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.00 to $121.90 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $122.15 to $122.74 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $123.19 to $123.52 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The option shares vested fully and became exercisable on November 20, 2019.
The option shares vested fully and became exercisable on April 1, 2020.
The option shares vested fully and became exercisable on March 21, 2021.
The option shares vest over four years. 25% of the option shares vested and became exercisable on March 9, 2019 and the remaining shares vest in 36 equal monthly installments thereafter.
/s/ Tami Chen, Attorney-in-Fact
2021-07-26